Introduction

Tiago Taidou interviews Professor Andrew Sideroff from the Department of Neurology, University of Pennsylvania in Philadelphia. The study looked at samples from the Parkinson's Progression Marker Initiative which is a longitudinal observational biomarker study involving large number of participants. It was a cross-sectional study and what we did is looked at Snuclein Seed Amplification which is a new biomarker.